Jefferies expects shares of U.K.-focused commercial real-estate stock Life Science REIT to rise by more than 60% over the next 12 months. The investment bank’s prediction comes at a time when the global commercial real estate market has seen prices fall sharply over the past year . In the U.K., capital values for commercial real estate have dropped by more than 20% from their peak in June 2022 — the sharpest correction since Lehman Brothers’ failure in 2008, according to a report by asset manager Schroders. The primary reason for this decline is an increase in interest rates and investor sentiment rather than falling rents, according to Schroders. In addition, the growing trend to work from home has not helped the sector. In response, both debt-backed buyers and investors with equity have demanded lower prices to meet their return targets. However, according to Jefferies, Life Science REIT will escape the